Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-12-13 Purchase |
2023-12-15 4:34 pm |
Cytosorbents Corp | CTSO | Deliargyris Efthymios Chief Medical Officer |
22,557 | $1.33 | $30,001 | 356,327 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-17 Exercise |
2025-01-22 8:33 pm |
N/A N/A |
Cytosorbents Corp | CTSO | Deliargyris Efthymios Chief Medical Officer |
16,233 | $1 | 435,491 (Direct) |
View |
2025-01-17 Exercise |
2025-01-22 8:33 pm |
2024-12-09 2025-01-10 |
Cytosorbents Corp | CTSO | Deliargyris Efthymios Chief Medical Officer |
16,233 | $0 | 435,491 (Direct) |
View |
2025-01-17 Other |
2025-01-22 8:33 pm |
2025-01-17 2025-02-24 |
Cytosorbents Corp | CTSO | Deliargyris Efthymios Chief Medical Officer |
32,466 | $0 | 435,491 (Direct) |
View |
2024-10-04 Option Award |
2024-10-08 9:00 pm |
N/A 2034-10-04 |
Cytosorbents Corp | CTSO | Deliargyris Efthymios Chief Medical Officer |
150,000 | $0 | 150,000 (Direct) |
View |
2024-04-02 Option Award |
2024-04-04 9:47 pm |
N/A 2034-04-02 |
Cytosorbents Corp | CTSO | Deliargyris Efthymios Chief Medical Officer |
147,000 | $0 | 495,433 (Direct) |
View |
2024-03-29 Option Award |
2024-04-02 9:32 pm |
N/A 2034-03-29 |
Cytosorbents Corp | CTSO | Deliargyris Efthymios Chief Medical Officer |
47,088 | $0 | 47,088 (Direct) |
View |
2023-07-07 Option Award |
2023-07-11 8:30 pm |
N/A 2033-07-07 |
Cytosorbents Corp | CTSO | Deliargyris Efthymios Chief Medical Officer |
173,000 | $0 | 449,648 (Direct) |
View |
2022-08-10 Option Award |
2022-08-12 6:49 pm |
N/A 2032-08-10 |
Cytosorbents Corp | CTSO | Deliargyris Efthymios Chief Medical Officer |
481,000 | $0 | 657,384 (Direct) |
View |
2021-04-12 Option Award |
2021-04-14 9:14 pm |
N/A N/A |
Cytosorbents Corp | CTSO | Deliargyris Efthymios Chief Medical Officer |
40,000 | $8.99 | 246,250 (Direct) |
View |
2021-04-12 Option Award |
2021-04-14 9:14 pm |
N/A 2031-04-12 |
Cytosorbents Corp | CTSO | Deliargyris Efthymios Chief Medical Officer |
63,250 | $0 | 246,250 (Direct) |
View |